These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33399347)

  • 21. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iatrogenic Palpitations during Exercise in a Patient with a Dual Chamber Implantable Cardioverter-Defibrillator and Lead Dysfunction.
    Hasegawa K; Miyazaki S; Kaseno K; Tada H
    Int Heart J; 2019 Mar; 60(2):462-465. PubMed ID: 30626767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technique for subcutaneous implantable cardioverter-defibrillator extraction.
    Ip JE
    J Cardiovasc Electrophysiol; 2019 May; 30(5):789-791. PubMed ID: 30815922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique technique to relieve left ventricular assist device electromagnetic interference with an implantable cardioverter defibrillator.
    Jin C; Hsu J; Frenkel D; Jacobson JT; Iwai S; Ferrick A
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):551-553. PubMed ID: 33345375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple ICD shocks in a patient with dilated cardiomyopathy: What is the mechanism?
    Fontenla A; López-Gil M; Rodríguez Muñoz D; Díez de Las Heras D; Arribas F
    J Cardiovasc Electrophysiol; 2019 May; 30(5):781-784. PubMed ID: 30688386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments in the subcutaneous ICD.
    Willcox ME; Prutkin JM; Bardy GH
    Trends Cardiovasc Med; 2016 Aug; 26(6):526-35. PubMed ID: 27079889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing.
    Miller MA; Palaniswamy C; Dukkipati SR; Balulad S; Smietana J; Vigdor A; Koruth JS; Choudry S; Whang W; Reddy VY
    J Am Coll Cardiol; 2017 Jun; 69(25):3118-3119. PubMed ID: 28641801
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with a left ventricular assist device: A case series and systematic review.
    Black-Maier E; Lewis RK; Barnett AS; Pokorney SD; Sun AY; Koontz JI; Daubert JP; Piccini JP
    Heart Rhythm; 2020 Sep; 17(9):1536-1544. PubMed ID: 32304733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. It's Always Something..
    Giudici MC
    J Am Heart Assoc; 2014 Apr; 3(2):e000947. PubMed ID: 24755157
    [No Abstract]   [Full Text] [Related]  

  • 32. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).
    Barsheshet A; Kutyifa V; Vamvouris T; Moss AJ; Biton Y; Chen L; Storozynsky E; Wan C; Szymkiewicz SJ; Goldenberg I
    J Cardiovasc Electrophysiol; 2017 Jul; 28(7):778-784. PubMed ID: 28429542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent, erratic behaviour of an implantable cardioverter defibrillator secondary to a hidden magnetic source of interference.
    Beinart R; Guy ML; Ellinor PT
    Europace; 2011 Oct; 13(10):1508-9. PubMed ID: 21576126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Submuscular Approach for Subcutaneous Implantable Cardioverter Defibrillator: A Potential Alternative Technique.
    Migliore F; Bottio T; Iliceto S; Bertaglia E
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):905. PubMed ID: 25704375
    [No Abstract]   [Full Text] [Related]  

  • 35. No Electromagnetic Interference Occurred in a Patient with a HeartMate II Left Ventricular Assist System and a Subcutaneous Implantable Cardioverter-Defibrillator.
    Raman AS; Shabari FR; Kar B; Loyalka P; Hariharan R
    Tex Heart Inst J; 2016 Apr; 43(2):183-5. PubMed ID: 27127441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electromagnetic interference from left ventricular assist device in patients with transvenous implantable cardioverter-defibrillator.
    Khetarpal BK; Lee JZ; Javaid AI; Mi L; Venepally NR; Narasimhan B; Hardaway BW; Cha YM; Kusumoto F; Mulpuru SK; Srivathsan K
    Pacing Clin Electrophysiol; 2021 Jul; 44(7):1163-1175. PubMed ID: 33977542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
    Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract]   [Full Text] [Related]  

  • 39. A shocking experience: inappropriate subcutaneous implantable cardioverter-defibrillator shock at a public swimming pool.
    Fastenrath FP; Kuschyk J; Borggrefe M; Akin I; Rudic B
    Europace; 2018 Dec; 20(12):2020. PubMed ID: 30252038
    [No Abstract]   [Full Text] [Related]  

  • 40. Device therapy: High-zone programming of ICDs reduces inappropriate shocks.
    Huynh K
    Nat Rev Cardiol; 2015 Apr; 12(4):193. PubMed ID: 25732361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.